BioSpace News Archive

Acentra Health, a leading provider of clinical services and technology solutions to government healthcare agencies, announced that Kepro has received full accreditation from URAC in Disease Management.

Quest Diagnostics today unveiled its new confirmatory testing service for novel psychoactive substances.

Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new integrated suite of advanced live cell imaging capabilities in December at Cell Bio 2023, the annual meeting of the American Society for Cell Biology.

Ablative Solutions, Inc., today announced that the TARGET BP I Pivotal Trial evaluating alcohol-mediated renal denervation with the Peregrine System ™ Kit met its primary endpoint, showing a statistically significant difference in 24-hour Ambulatory Blood Pressure between treatment and sham procedure at 3 months.

Syros Pharmaceuticals announced today that it has priced an underwritten offering of 4,939,591 shares of common stock at an offering price of $4.42 per share.

Day One Biopharmaceuticals today announced that Dr. Jeremy Bender, chief executive officer, will present during the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8 at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time.

As we bid farewell to 2023, it is with great enthusiasm that we share with you the accomplishments and progress that the Thryv team has achieved over the past year.

Lassen Therapeutics today announced the closing of an oversubscribed Series B financing which raised $85 million.

Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024.

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced grants awarded to support clinical studies that will evaluate the efficacy and safety of elranatamab in the treatment of multiple myeloma.